Stock DLCL6 DR LALCHANDANI LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Dr Lalchandani Labs Limited

Equities

DLCL6

INE871Z01013

Delayed Bombay S.E.
Other stock markets
 06:00:51 2024-05-29 EDT 		5-day change 1st Jan Change
22.93 INR +4.99% Intraday chart for Dr Lalchandani Labs Limited +5.81% +8.01%
05-02 Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer CI
04-06 Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Dr Lalchandani Labs Limited Approves Appointment of Namita Anand as Company Secretary and Compliance Officer
CI
Dr Lalchandani Labs Limited Announces Resignation of Karan Kumar as Company Secretary and Compliance Officer
CI
Dr Lalchandani Labs Limited Announces the Resignation of Archana R Jha as Company Secretary and Compliance Officer
CI
Dr Lalchandani Labs Limited Approves Resignation of Monika Joshi as Company Secretary and Compliance Officer
CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Dr Lalchandani Labs Limited Announces Resignation of Archana Jha from the Office of Company Secretary
CI
Dr Lalchandani Labs Limited Appoints Monika Joshi as Company Secretary and Compliance Officer, Effective August 27, 2023
CI
Dr Lalchandani Labs Limited Announces Resignation of Archana R Jha as Company Secretary
CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Dr Lalchandani Labs Limited Announces Management Changes
CI
Dr Lalchandani Labs Limited Appoints Archana Jha as Company Secretary & Compliance Officer
CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2022
CI
Dr Lalchandani Labs Limited Announces Resignation of CS Swati Poddar as Company Secretary and Compliance Officer
CI
Dr Lalchandani Labs Limited Resumes in Full Capacity At the Lab in Punjabi Bagh
CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Dr Lalchandani Labs to Provide Diagnostic Services in Delhi, India, as Part of New Deal
MT
Dr Lalchandani Labs Limited Appoints Swati Chandra as Additional Director
CI
Dr Lalchandani Labs Limited Announces Resignation of Ms. Manica Gupta as Non-Executive Director
CI
Dr Lalchandani Labs Limited Reports Earnings Results for the Half Year Ended September 30, 2021
CI
Dr Lalchandani Labs' : Net Profit Soars in Fiscal Q4
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DLCL6 Stock
  4. News Dr Lalchandani Labs Limited